Up-regulation of toll-like receptor 9 in osteosarcoma

Anticancer Research

Volumn 35, Issue 11, 2015, Pages 5839-5843

  Jing, Yongbin ^a   Liang, Hongbin ^b   Zhang, Yifan ^b   Cleveland, Joseph ^b   Yan, Jinglong ^a   Zhang, Dekai ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Innate immunity; MG 63 cells; Osteosarcoma; TLR9; Toll like receptor

Indexed keywords

TOLL LIKE RECEPTOR 9; MESSENGER RNA; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; DISEASE COURSE; DISTANT METASTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LYMPH NODE METASTASIS; MACROPHAGE; MAJOR CLINICAL STUDY; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; YOUNG ADULT; BONE TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENETICS; MALE; METABOLISM; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; TUMOR CELL CULTURE;

ADULT; BONE NEOPLASMS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; NEOPLASM GRADING; OSTEOSARCOMA; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTORS; TUMOR CELLS, CULTURED; UP-REGULATION; YOUNG ADULT;

EID: 84946050817     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mackall CL, Merchant MS and Fry TJ: Immune-based therapies for childhood cancer. Nat Rev Clin Oncol 11: 693-703, 2014.
2. Pui CH, Gajjar AJ, Kane JR, Qaddoumi IA and Pappo AS: Challenging issues in pediatric oncology. Nat Rev Clin Oncol 8: 540-549, 2011.
3. Akira S, Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell 124: 783-801, 2006.
4. Beutler B: Toll-like receptors: how they work and what they do. Curr Opin Hematol 9: 2-10, 2002.
5. Rakoff-Nahoum S and Medzhitov R: Toll-like receptors and cancer. Nat Rev Cancer 9: 57-63, 2009.
6. Janeway CA Jr.: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54 Pt 1: 1-13, 1989.
7. Beg AA: Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 23: 509-512, 2002.
8. Cai Z, Sanchez A, Shi Z, Zhang T, Liu M and Zhang D: Activation of toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res 71: 2466-2475, 2011.
9. Luo JL, Maeda S, Hsu LC, Yagita H and Karin M: Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer cell 6: 297-305, 2004.
10. Salaun B, Coste I, Rissoan MC, Lebecque SJ and Renno T: TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176: 4894-4901, 2006.
11. O'Neill LA and Bowie AG: The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364, 2007.
12. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA and Ghosh S: A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526, 2004.
13. Krieg AM: Development of TLR9 agonists for cancer therapy. J Clin Invest 117: 1184-1194, 2007.
14. Salaun B, Lebecque S, Matikainen S, Rimoldi D and Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13: 4565-4574, 2007.
15. Shi Z, Cai Z, Sanchez A, Zhang T, Wen S, Wang J, Yang J, Fu S and Zhang D: A novel Toll-like receptor that recognizes vesicular stomatitis virus. J Biol Chem 286: 4517-4524, 2011.
16. Zhao S, Zhang Y, Zhang Q, Wang F and Zhang D: Toll-like receptors and prostate cancer. Front Immunol 5(352): 1-6, 2014.
17. Pradere JP, Dapito DH and Schwabe RF: The Yin and Yang of Toll-like receptors in cancer. Oncogene 33: 3485-3495, 2014.
18. Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med 19: 1423-1437, 2013.
19. Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B and Bernstein H: Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 85: 863-871, 2011.
20. Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T and Ushijima T: Early-stage formation of an epigenetic field defect in a mouse colitis model and non-essential roles of T-and B-cells in DNA methylation induction. Oncogene 31: 342-351, 2012.
21. Takeuchi O and Akira S: Pattern recognition receptors and inflammation. Cell 140: 805-820, 2010.
22. Guiducci C, Gong M, Xu Z, Gill M, Chaussabel D, Meeker T, Chan JH, Wright T, Punaro M, Bolland S, Soumelis V, Banchereau J, Coffman RL, Pascual V and Barrat FJ: TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465: 937-941, 2010.
23. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K and Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745, 2000.
24. Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S and Wagner H: Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Eex Med 192: 595-600, 2000.
25. Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760, 2002.
26. Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y, Furutani Y, Yano O, Kataoka T and Sudo T: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization and antitumor activity. J Natl Cancer Inst 72: 955-962, 1984.